240 related articles for article (PubMed ID: 25728022)
1. Purine-benzimidazole hybrids: synthesis, single crystal determination and in vitro evaluation of antitumor activities.
Sharma A; Luxami V; Paul K
Eur J Med Chem; 2015 Mar; 93():414-22. PubMed ID: 25728022
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids.
Sharma A; Luxami V; Paul K
Bioorg Med Chem Lett; 2013 Jun; 23(11):3288-94. PubMed ID: 23611732
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazole-Based Quinazolines: In Vitro Evaluation, Quantitative Structure-Activity Relationship, and Molecular Modeling as Aurora Kinase Inhibitors.
Sharma A; Luxami V; Saxena S; Paul K
Arch Pharm (Weinheim); 2016 Mar; 349(3):193-201. PubMed ID: 26773437
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitumor evaluation of primary amine substituted quinazoline linked benzimidazole.
Paul K; Sharma A; Luxami V
Bioorg Med Chem Lett; 2014 Jan; 24(2):624-9. PubMed ID: 24360999
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of 2-substituted benzimidazoles and their evaluation as anticancer agent.
Azam M; Khan AA; Al-Resayes SI; Islam MS; Saxena AK; Dwivedi S; Musarrat J; Trzesowska-Kruszynska A; Kruszynski R
Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 142():286-91. PubMed ID: 25706598
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
Yoon YK; Ali MA; Wei AC; Shirazi AN; Parang K; Choon TS
Eur J Med Chem; 2014 Aug; 83():448-54. PubMed ID: 24992072
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
El-Nassan HB
Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
13. New benzimidazoles and their antitumor effects with Aurora A kinase and KSP inhibitory activities.
Abd El-All AS; Magd-El-Din AA; Ragab FA; ElHefnawi M; Abdalla MM; Galal SA; El-Rashedy AA
Arch Pharm (Weinheim); 2015 Jul; 348(7):475-86. PubMed ID: 25900113
[TBL] [Abstract][Full Text] [Related]
14. Triazine-benzimidazole hybrids: anticancer activity, DNA interaction and dihydrofolate reductase inhibitors.
Singla P; Luxami V; Paul K
Bioorg Med Chem; 2015 Apr; 23(8):1691-700. PubMed ID: 25792141
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition.
Fan C; Zhong T; Yang H; Yang Y; Wang D; Yang X; Xu Y; Fan Y
Eur J Med Chem; 2020 Mar; 190():112108. PubMed ID: 32058239
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors.
Akhtar MJ; Siddiqui AA; Khan AA; Ali Z; Dewangan RP; Pasha S; Yar MS
Eur J Med Chem; 2017 Jan; 126():853-869. PubMed ID: 27987485
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
Shi L; Wu TT; Wang Z; Xue JY; Xu YG
Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
[TBL] [Abstract][Full Text] [Related]
19. 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation.
Abou-Seri SM; Eldehna WM; Ali MM; Abou El Ella DA
Eur J Med Chem; 2016 Jan; 107():165-79. PubMed ID: 26590508
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
Kamal A; Rao AV; Nayak VL; Reddy NV; Swapna K; Ramakrishna G; Alvala M
Org Biomol Chem; 2014 Dec; 12(48):9864-80. PubMed ID: 25354805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]